Ligandrol (LGD-4033) Liquid

Buy Ligandrol (LGD-4033) Liquid Online

Ligandrol (LGD-4033) is a potent selective androgen receptor modulator with human clinical research examining its effects on lean body mass, hormone levels, lipid parameters, and pharmacokinetics.

Product Information

LGD-4033 is a nonsteroidal SARM that binds androgen receptors with high affinity. The liquid format is a formulation characteristic; the active compound remains LGD-4033. Also known as Ligandrol or LGD, LGD-4033 is one of the better-characterized SARMs in human clinical research.

How It Works

LGD-4033 activates androgen receptors in a tissue-selective manner. Human research has shown that this can increase lean body mass while simultaneously producing measurable endocrine and lipid changes.

POTENTIAL BENEFITS

1. Lean Body Mass Research

Clinical research has shown dose-dependent increases in lean body mass during short-term administration, making LGD-4033 particularly relevant to anabolic research.

2. Selective Androgen Signaling

Ligandrol allows researchers to study androgen-receptor activation without using conventional anabolic steroids, providing a distinct model of selective receptor pharmacology.

3. Muscle Research

Changes in lean mass and muscle-related parameters have been examined in controlled human research, supporting continued investigation of LGD-4033 in muscle biology.

4. Pharmacology Research

Its relatively long half-life and dose-dependent accumulation make LGD-4033 useful for investigating repeated exposure, pharmacokinetics, and endocrine adaptation.

Dosage

The best-characterized human study used 0.1, 0.3, or 1.0 mg daily for 21 days. Because these doses were evaluated under controlled clinical conditions and produced measurable hormonal and lipid effects, they should not be interpreted as a safe self-use protocol.

Side Effects

Potential concerns include suppression of testosterone and SHBG, reductions in HDL cholesterol, and liver injury. A published case report documented severe drug-induced liver injury following non-medical LGD-4033 use.

References

1. Basaria et al. — LGD-4033 safety, pharmacokinetics, and effects in healthy young men. PMID: 22459616
2. Ligandrol (LGD-4033)-Induced Liver Injury. PMID: 32637435
3. PubMed — LGD-4033 pharmacology and clinical research

Note: BehemothLabz does not sell this product. Purchase links on this page may direct you to third-party suppliers through affiliate links.

Please click here to see how purchases actually work on this site.